These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 8217065

  • 1. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM, Stewart JW, McGrath PJ, Tricamo E, Rabkin JG, Ocepek-Welikson K, Nunes E, Harrison W, Klein DF.
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [Abstract] [Full Text] [Related]

  • 2. Defining the boundaries of atypical depression.
    Quitkin FM, Harrison W, Liebowitz M, McGrath P, Rabkin JG, Stewart J, Markowitz J.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):19-21. PubMed ID: 6376482
    [Abstract] [Full Text] [Related]

  • 3. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [Abstract] [Full Text] [Related]

  • 4. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
    Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG.
    Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
    [Abstract] [Full Text] [Related]

  • 5. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Wager SG, Nunes E, Rabkin JG, Tricamo E, Markowitz J, Klein DF.
    Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
    [Abstract] [Full Text] [Related]

  • 6. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ, Stewart JW, Nunes EN, Quitkin FM.
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [Abstract] [Full Text] [Related]

  • 7. Psychopharmacologic validation of atypical depression.
    Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin JG, Tricamo E, Markowitz JS, Klein DF.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [Abstract] [Full Text] [Related]

  • 8. Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
    Parsons B, Quitkin FM, McGrath PJ, Stewart JW, Tricamo E, Ocepek-Welikson K, Harrison W, Rabkin JG, Wager SG, Nunes E.
    Psychopharmacol Bull; 1989 Jul; 25(4):524-34. PubMed ID: 2698483
    [Abstract] [Full Text] [Related]

  • 9. [Impact of personality factors in depression].
    Quitkin FM.
    Encephale; 1993 Aug; 19 Spec No 3():491-2. PubMed ID: 8299548
    [Abstract] [Full Text] [Related]

  • 10. Predictive value of symptoms of atypical depression for differential drug treatment outcome.
    McGrath PJ, Stewart JW, Harrison WM, Ocepek-Welikson K, Rabkin JG, Nunes EN, Wager SG, Tricamo E, Quitkin FM, Klein DF.
    J Clin Psychopharmacol; 1992 Jun; 12(3):197-202. PubMed ID: 1629387
    [Abstract] [Full Text] [Related]

  • 11. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G, Saxena BM, Nair NP, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA.
    Clin Neuropharmacol; 1993 Jun; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [Abstract] [Full Text] [Related]

  • 12. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW, McGrath PJ, Quitkin FM, Rabkin JG, Harrison W, Wager S, Nunes E, Ocepek-Welikson K, Tricamo E.
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [Abstract] [Full Text] [Related]

  • 13. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA, Mesones HL, Brengio F.
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [Abstract] [Full Text] [Related]

  • 14. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
    Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, Wager SG, Ocepek-Welikson K, Nunes E, Rabkin JG, Klein DF.
    Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
    [Abstract] [Full Text] [Related]

  • 15. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC.
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [Abstract] [Full Text] [Related]

  • 16. Treating DSM-IV depression with atypical features.
    Stewart JW, Thase ME.
    J Clin Psychiatry; 2007 Apr; 68(4):e10. PubMed ID: 17474800
    [Abstract] [Full Text] [Related]

  • 17. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W, Rabkin J, Stewart JW, McGrath PJ, Tricamo E, Quitkin F.
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [Abstract] [Full Text] [Related]

  • 18. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP, Herbstein J, Damlouji N.
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [Abstract] [Full Text] [Related]

  • 19. Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
    Thase ME, Frank E, Mallinger AG, Hamer T, Kupfer DJ.
    J Clin Psychiatry; 1992 Jan; 53(1):5-11. PubMed ID: 1737741
    [Abstract] [Full Text] [Related]

  • 20. Course and treatment of atypical depression.
    Nierenberg AA, Alpert JE, Pava J, Rosenbaum JF, Fava M.
    J Clin Psychiatry; 1998 Jan; 59 Suppl 18():5-9. PubMed ID: 9840192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.